Research ArticleOriginal Article
Open Access

Association of total antioxidants level with glaucoma type and severity

Ahmed Mousa, Altaf A. Kondkar, Saleh A. Al-Obeidan, Taif A. Azad, Tahira Sultan, Essam Osman and Khaled K. Abu-Amero
Saudi Medical Journal June 2015, 36 (6) 671-677; DOI: https://doi.org/10.15537/smj.2015.6.10697

References

  1. ↵
    1. Quigley HA,
    2. Broman AT
    (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262–267.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Krakau CE
    (1981) Intraocular pressure elevation-cause or effect in chronic glaucoma? Ophthalmologica 182:141–147.
    OpenUrlPubMedWeb of Science
  3. ↵
    1. Bonomi L,
    2. Marchini G,
    3. Marraffa M,
    4. Morbio R
    (2001) The relationship between intraocular pressure and glaucoma in a defined population. Data from the Egna-Neumarkt Glaucoma Study. Ophthalmologica 215:34–38.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Johnson TV,
    2. Tomarev SI
    (2010) Rodent models of glaucoma. Brain Res Bull 81:349–358.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Butt Z,
    2. O’Brien C,
    3. McKillop G,
    4. Aspinall P,
    5. Allan P
    (1997) Color Doppler imaging in untreated high- and normal-pressure open-angle glaucoma. Invest Ophthalmol Vis Sci 38:690–696.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Veach J
    (2004) Functional dichotomy: glutathione and vitamin E in homeostasis relevant to primary open-angle glaucoma. Br J Nutr 91:809–829.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Izzotti A,
    2. Saccà SC,
    3. Cartiglia C,
    4. De Flora S
    (2003) Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med 114:638–646.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Ohia SE,
    2. Opere CA,
    3. Leday AM
    (2005) Pharmacological consequences of oxidative stress in ocular tissues. Mutat Res 579:22–36.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Saccà SC,
    2. Pascotto A,
    3. Camicione P,
    4. Capris P,
    5. Izzotti A
    (2005) Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol 123:458–463.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Abu-Amero KK,
    2. Morales J,
    3. Bosley TM
    (2006) Mitochondrial abnormalities in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 47:2533–2541.
    OpenUrlAbstract/FREE Full Text
    1. Abu-Amero KK,
    2. Cabrera VM,
    3. Larruga JM,
    4. Osman EA,
    5. González AM,
    6. Al-Obeidan SA
    (2011) Eurasian and Sub-Saharan African mitochondrial DNA haplogroup influences pseudoexfoliation glaucoma development in Saudi patients. Mol Vis 17:543–547.
    OpenUrlPubMed
  12. ↵
    1. Bosley TM,
    2. Hellani A,
    3. Spaeth GL,
    4. Myers J,
    5. Katz LJ,
    6. Moster MR,
    7. et al.
    (2011) Down-regulation of OPA1 in patients with primary open angle glaucoma. Mol Vis 17:1074–1079.
    OpenUrlPubMed
  13. ↵
    1. Abu-Amero KK,
    2. Morales J,
    3. Mohamed GH,
    4. Osman MN,
    5. Bosley TM
    (2008) Glutathione S-transferase M1 and T1 polymorphisms in Arab glaucoma patients. Mol Vis 14:425–430.
    OpenUrlPubMedWeb of Science
  14. ↵
    1. Nucci C,
    2. Di Pierro D,
    3. Varesi C,
    4. Ciuffoletti E,
    5. Russo R,
    6. Gentile R,
    7. et al.
    (2013) Increased malondialdehyde concentration and reduced total antioxidant capacity in aqueous humor and blood samples from patients with glaucoma. Mol Vis 19:1841–1846.
    OpenUrl
  15. ↵
    1. Erdurmuş M,
    2. Yağcı R,
    3. Atış Ö,
    4. Karadağ R,
    5. Akbaş A,
    6. Hepşen IF
    (2011) Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma. Curr Eye Res 36:713–718.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Sorkhabi R,
    2. Ghorbanihaghjo A,
    3. Javadzadeh A,
    4. Rashtchizadeh N,
    5. Moharrery M
    (2011) Oxidative DNA damage and total antioxidant status in glaucoma patients. Mol Vis 17:41–46.
    OpenUrlPubMed
  17. ↵
    1. Engin KN,
    2. Yemişci B,
    3. Yiğit U,
    4. Ağaçhan A,
    5. Coşkun C
    (2010) Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patients. Mol Vis 16:1260–1271.
    OpenUrlPubMed
  18. ↵
    1. Abu-Amero KK,
    2. Kondkar AA,
    3. Mousa A,
    4. Osman EA,
    5. Al-Obeidan SA
    (2011) Decreased total antioxidants status in the plasma of patients with pseudoexfoliation glaucoma. Mol Vis 17:2769–2775.
    OpenUrlPubMed
  19. ↵
    1. Abu-Amero KK,
    2. Azad TA,
    3. Mousa A,
    4. Osman EA,
    5. Sultan T,
    6. Al-Obeidan SA
    (2014) Total antioxidant level is correlated with intra-ocular pressure in patients with primary angle closure glaucoma. BMC Res Notes 7:163.
    OpenUrl
  20. ↵
    1. Abu-Amero KK,
    2. Kondkar AA,
    3. Mousa A,
    4. Osman EA,
    5. Al-Obeidan SA
    (2013) Decreased total antioxidants in patients with primary open angle glaucoma. Curr Eye Res 38:959–964.
    OpenUrl
  21. ↵
    European Glaucoma Society. Terminology and guidelines for glaucoma. [Updated: 2015; Accessed 2014 October 2014], Available from: http://www.eugs.org/eng/EGS_guidelines.asp). 3rd ed.
  22. ↵
    1. Tulunoglu O,
    2. Demirtas S,
    3. Tulunoglu I
    (2006) Total antioxidant levels of saliva in children related to caries, age, and gender. Int J Paediatr Dent 16:186–191.
    OpenUrlPubMed
  23. ↵
    1. Abu-Amero KK,
    2. Bosley TM,
    3. Morales J
    (2008) Analysis of nuclear and mitochondrial genes in patients with pseudoexfoliation glaucoma. Mol Vis 14:29–36.
    OpenUrlPubMed
  24. ↵
    1. Ritch R,
    2. Shields M,
    3. Krupin T
    , eds Angle-closure glaucoma: mechanisms and epidemiology. In: The Glaucomas (Mosby, St Louis (MO)) 1996. p. 801-819, 2nd ed.
  25. ↵
    1. Quigley HA,
    2. Friedman DS,
    3. Congdon NG
    (2003) Possible mechanisms of primary angle-closure and malignant glaucoma. J Glaucoma 12:167–180.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. de Kater AW,
    2. Melamed S,
    3. Epstein DL
    (1989) Patterns of aqueous humor outflow in glaucomatous and nonglaucomatous human eyes. A tracer study using cationized ferritin. Arch Ophthalmol 107:572–576.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Quigley HA,
    2. Friedman DS,
    3. Congdon NG
    (1997) Possible mechanisms of primary angle-closure and malignant glaucoma. J Glaucoma 6:123–132.
    OpenUrlPubMedWeb of Science
  28. ↵
    1. Tezel G
    (2006) Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 25:490–513.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    1. Abu-Amero KK,
    2. Morales J,
    3. Osman MN,
    4. Bosley TM
    (2007) Nuclear and mitochondrial analysis of patients with primary angle-closure glaucoma. Invest Ophthalmol Vis Sci 48:5591–5596.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Gherghel D,
    2. Griffiths HR,
    3. Hilton EJ,
    4. Cunliffe IA,
    5. Hosking SL
    (2005) Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 46:877–883.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Zanon-Moreno V,
    2. Marco-Ventura P,
    3. Lleo-Perez A,
    4. Pons-Vazquez S,
    5. Garcia-Medina JJ,
    6. Vinuesa-Silva I,
    7. et al.
    (2008) Oxidative stress in primary open-angle glaucoma. J Glaucoma 17:263–268.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section